Skip to content
Screener

Beta Bionics BBNX Q4 2025 Annual earnings

Reported February 17, 2026 · After market close

Revenue$32.1MBeat by $1.7M
EPS-$0.30Beat by $0.12
Revenue estimate$30.4M
EPS estimate-$0.42

Next report

Oct 27, 2026 (in 2 months)
Revenue estimate$35.0M
EPS estimate-$0.55

Financials

Q4 2025

Income statement

See full
Revenue$32.1M+57.1%
Gross profit$18.9M+62.1%
Operating income-$16.1M-23.7%
Net income-$13.5M+25.6%
EPS (diluted)-$0.29+89.4%

Balance sheet

See full
Cash & equivalents$31.6M+3.8%
Total debt$7.3M+0.7%
Total equity$287.6M+217%
Total assets$328.7M+120%

Cash flow

See full
Operating cash flow-$8.6M+39.6%
CapEx$1.9M+239%
Free cash flow-$10.5M+29.0%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.34B—
Enterprise value$1.32B—
P/S13.4×—

Profitability

See full
Gross margin55.4%+0.3pp
Operating margin-71.5%+2.1pp
Net margin-73%-8.5pp
FCF margin-56.1%-12.7pp

Returns & leverage

See full
Debt / equity0×—
Current ratio8.7×+2.4×

Segments

By product

See full
I Let$14.8M+9.8%
Single Use Products$7.5M+68.5%

By geography

See full
Non Us-—

FAQ

When did Beta Bionics report Q4 2025 earnings?
Beta Bionics (BBNX) reported Q4 2025 earnings on February 17, 2026 after market close.
What were Beta Bionics's Q4 2025 revenue and EPS?
Beta Bionics reported revenue of $32.1M and eps of $-0.30 for Q4 2025.
Did Beta Bionics beat estimates in Q4 2025?
Revenue beat the consensus estimate of $30.4M by $1.7M. EPS beat the consensus estimate of $-0.42 by $0.12.
How did Beta Bionics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 57.1% from $20.4M a year earlier and eps grew 83.5% from $-1.82.
Where can I find Beta Bionics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001171843-26-000859) and the 10-K periodic report (0001193125-26-067065) directly on SEC EDGAR. The filing index links above go to sec.gov.